Our research has a significant national and international impact on the treatment and outlook of people experiencing Post Traumatic Stress Disorder (PTSD) and of those around them. The Traumatic Stress Research Group works closely with partners to pioneer new treatments and to understand more about the causes and effects of PTSD.

The following are studies that are currently being conducted at the university and in collaboration with colleagues:




Reading Glasses

We are trying to understand why some people experience problems with their mental health. The purpose of this study is to collect information and samples for genetic, biological, psychological and clinical research.


RAPID is a pragmatic randomised controlled trial of a trauma-focused Guided Self Help programme versus Individual Trauma-Focused Cognitive Behavioural Therapy for Post-Traumatic Stress Disorder.

RAPID 4 Step 1 Learning about my PTSD_preview.png


IMG_8892 copy_preview.jpeg

Modular Motion assisted Memory Desensitization and Reconsolidation (3MDR) is a new treatment, developed in The Netherlands, that incorporates key elements of successful treatments such as Virtual Reality Exposure (VRE) and Eye Movement Desensitization Reprocessing (EMDR) and adds motion through walking on a treadmill. 



MDMA is a drug that affects a number of chemicals in the brain, including ones that may help PTSD sufferers. 



The Traumatic Stress Research Group is at the international forefront of systematically reviewing and synthesising knowledge from randomised controlled trials to provide evidence-based guidance with respect to the prevention and treatment of PTSD. 

The PTSD Registry was set up by Dr Neil Roberts, Professor Jonathan Bisson and Dr Neil Kitchiner in order to support the development of research into the condition Posttraumatic Stress Disorder (PTSD) and associated trauma related conditions.